PubMed

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression.

Sridhar K, Ross DT, Tibshirani R, Butte AJ, Greenberg PL.

Blood. 2009 Oct 2. [Epub ahead of print]PMID: 19801443 [PubMed - as supplied by publisher]Related articles

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996).

Greenberg PL, Sun Z, Miller KB, Bennett JM, Tallman MS, Dewald G, Paietta E, van der Jagt R, Houston J, Thomas ML, Cella D, Rowe JM.

Blood. 2009 Sep 17;114(12):2393-400. Epub 2009 Jun 29.PMID: 19564636 [PubMed - indexed for MEDLINE]Related articles

A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes.

Gotlib J, Lavori P, Quesada S, Stein RS, Shahnia S, Greenberg PL.

Am J Hematol. 2009 Jan;84(1):15-20.PMID: 19006226 [PubMed - indexed for MEDLINE]Related articles

The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines.

Greenberg PL, Cosler LE, Ferro SA, Lyman GH.

J Natl Compr Canc Netw. 2008 Oct;6(9):942-53.PMID: 18926103 [PubMed - indexed for MEDLINE]Related articles

Myelodysplastic syndromes.

Greenberg PL, Attar E, Battiwalla M, Bennett JM, Bloomfield CD, DeCastro CM, Deeg HJ, Erba HP, Foran JM, Garcia-Manero G, Gore SD, Head D, Maness LJ, Millenson M, Nimer SD, O'Donnell MR, Saba HI, Shami PJ, Spiers K, Stone RM, Tallman MS, Westervelt P; NCCN Myelodysplastic Syndromes Panel.

J Natl Compr Canc Netw. 2008 Oct;6(9):902-26. No abstract available. PMID: 18926100 [PubMed - indexed for MEDLINE]Related articles

International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes.

Kao JM, McMillan A, Greenberg PL.

Am J Hematol. 2008 Oct;83(10):765-70.PMID: 18645988 [PubMed - indexed for MEDLINE]Related articles

A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia.

Raponi M, Lancet JE, Fan H, Dossey L, Lee G, Gojo I, Feldman EJ, Gotlib J, Morris LE, Greenberg PL, Wright JJ, Harousseau JL, Löwenberg B, Stone RM, De Porre P, Wang Y, Karp JE.

Blood. 2008 Mar 1;111(5):2589-96. Epub 2007 Dec 26.PMID: 18160667 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.

Raza A, Reeves JA, Feldman EJ, Dewald GW, Bennett JM, Deeg HJ, Dreisbach L, Schiffer CA, Stone RM, Greenberg PL, Curtin PT, Klimek VM, Shammo JM, Thomas D, Knight RD, Schmidt M, Wride K, Zeldis JB, List AF.

Blood. 2008 Jan 1;111(1):86-93. Epub 2007 Sep 24.PMID: 17893227 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic myelogenous leukemia.

O'Brien S, Berman E, Bhalla K, Copelan EA, Devetten MP, Emanuel PD, Erba HP, Greenberg PL, Moore JO, Przepiorka D, Radich JP, Schilder RJ, Shami P, Smith BD, Snyder DS, Soiffer RJ, Tallman MS, Talpaz M, Wetzler M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2007 May;5(5):474-96. No abstract available. PMID: 17509252 [PubMed - indexed for MEDLINE]Related articles

A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia.

Lancet JE, Gojo I, Gotlib J, Feldman EJ, Greer J, Liesveld JL, Bruzek LM, Morris L, Park Y, Adjei AA, Kaufmann SH, Garrett-Mayer E, Greenberg PL, Wright JJ, Karp JE.

Blood. 2007 Feb 15;109(4):1387-94. Epub 2006 Nov 2.PMID: 17082323 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia.

Cheson BD, Greenberg PL, Bennett JM, Lowenberg B, Wijermans PW, Nimer SD, Pinto A, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Gore SD, Schiffer CA, Kantarjian H.

Blood. 2006 Jul 15;108(2):419-25. Epub 2006 Apr 11.PMID: 16609072 [PubMed - indexed for MEDLINE]Related articlesFree article

Myelodysplastic syndromes: iron overload consequences and current chelating therapies.

Greenberg PL.

J Natl Compr Canc Netw. 2006 Jan;4(1):91-6. Review.PMID: 16403408 [PubMed - indexed for MEDLINE]Related articles

Myelodysplastic syndromes clinical practice guidelines in oncology.

Greenberg PL, Baer MR, Bennett JM, Bloomfield CD, De Castro CM, Deeg HJ, Devetten MP, Emanuel PD, Erba HP, Estey E, Foran J, Gore SD, Millenson M, Navarro WH, Nimer SD, O'Donnell MR, Saba HI, Spiers K, Stone RM, Tallman MS.

J Natl Compr Canc Netw. 2006 Jan;4(1):58-77. No abstract available. Erratum in: J Natl Compr Canc Netw. 2006 Mar;4(3):table of contents. Dosage error in article text. PMID: 16403405 [PubMed - indexed for MEDLINE]Related articles

Chronic myelogenous leukemia.

O'Brien S, Berman E, Bhalla K, Copelan EA, Devetten MP, Emanuel PD, Erba HP, Greenberg PL, Moore JO, Przepiorka D, Radich JP, Schilder RJ, Shami P, Smith BD, Snyder DS, Soiffer RJ, Tallman MS, Talpaz M, Wetzler M.

J Natl Compr Canc Netw. 2005 Nov;3(6):732-55. No abstract available. PMID: 16316611 [PubMed - indexed for MEDLINE]Related articles

Management of patients with higher risk myelodysplastic syndromes.

Fukumoto JS, Greenberg PL.

Crit Rev Oncol Hematol. 2005 Nov;56(2):179-92. Epub 2005 Jun 23. Review.PMID: 15979321 [PubMed - indexed for MEDLINE]Related articles

Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

Greenberg PL, Lee SJ, Advani R, Tallman MS, Sikic BI, Letendre L, Dugan K, Lum B, Chin DL, Dewald G, Paietta E, Bennett JM, Rowe JM.

J Clin Oncol. 2004 Mar 15;22(6):1078-86. Erratum in: J Clin Oncol. 2004 Jul 1;22(13):2747. PMID: 15020609 [PubMed - indexed for MEDLINE]Related articles

Novel biospecific agents for the treatment of myelodysplastic syndromes.

Gotlib J, Greenberg PL.

J Natl Compr Canc Netw. 2003 Oct;1(4):473-80. Review.PMID: 19774739 [PubMed - indexed for MEDLINE]Related articles

Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.

Cherry AM, Brockman SR, Paternoster SF, Hicks GA, Neuberg D, Higgins RR, Bennett JM, Greenberg PL, Miller K, Tallman MS, Rowe J, Dewald GW.

Leuk Res. 2003 Dec;27(12):1085-90.PMID: 12921944 [PubMed - indexed for MEDLINE]Related articles

Myelodysplastic syndromes.

Greenberg PL, Young NS, Gattermann N.

Hematology Am Soc Hematol Educ Program. 2002:136-61. Review.PMID: 12446422 [PubMed - indexed for MEDLINE]Related articlesFree article

Major hematologic diseases in the developing world- new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia.

Greenberg PL, Gordeuk V, Issaragrisil S, Siritanaratkul N, Fucharoen S, Ribeiro RC.

Hematology Am Soc Hematol Educ Program. 2001:479-98. Review.PMID: 11723000 [PubMed - indexed for MEDLINE]Related articlesFree article

Myelodysplastic syndromes standardized response criteria: further definition.

Cheson BD, Bennett JM, Kantarjian H, Schiffer CA, Nimer SD, Löwenberg B, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Greenberg PL.

Blood. 2001 Sep 15;98(6):1985. No abstract available. PMID: 11535540 [PubMed - indexed for MEDLINE]Related articlesFree article

NCCN Practice Guidelines for Chronic Myelogenous Leukemia.

Berman E, Clift RA, Copelan EA, Emanuel PD, Erba HP, Glenn MJ, Greenberg PL, Jones RJ, O'Brien S, Saba HI, Schilder R, Snyder DS, Soiffer RJ, Tallman MS, Wetzler M, Ravandi-Kashani F, Kantarjian H, Talpaz M; National Comprehensive Cancer Network.

Oncology (Williston Park). 2000 Nov;14(11A):229-40. No abstract available. PMID: 11195415 [PubMed - indexed for MEDLINE]Related articles

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, Löwenberg B, Beran M, de Witte TM, Stone RM, Mittelman M, Sanz GF, Wijermans PW, Gore S, Greenberg PL; World Health Organization(WHO) international working group.

Blood. 2000 Dec 1;96(12):3671-4.PMID: 11090046 [PubMed - indexed for MEDLINE]Related articlesFree article

An apology.

Greenberg PL.

J Hematother Stem Cell Res. 1999 Aug;8(4):333. No abstract available. PMID: 10634170 [PubMed - indexed for MEDLINE]Related articles

Prognostic scoring systems for risk assessment in myelodysplastic syndromes.

Greenberg PL, Sanz GF, Sanz MA.

Forum (Genova). 1999 Jan-Mar;9(1):17-31. Review.PMID: 10101208 [PubMed - indexed for MEDLINE]Related articles

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment.

Greenberg PL.

Leuk Res. 1998 Dec;22(12):1123-36. Review.PMID: 9922076 [PubMed - indexed for MEDLINE]Related articles

Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar).

Advani R, Saba HI, Tallman MS, Rowe JM, Wiernik PH, Ramek J, Dugan K, Lum B, Villena J, Davis E, Paietta E, Litchman M, Sikic BI, Greenberg PL.

Blood. 1999 Feb 1;93(3):787-95.PMID: 9920827 [PubMed - indexed for MEDLINE]Related articlesFree article

Risk factors and their relationship to prognosis in myelodysplastic syndromes.

Greenberg PL.

Leuk Res. 1998 May;22 Suppl 1:S3-6. Review.PMID: 9734692 [PubMed - indexed for MEDLINE]Related articles

Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression.

Davis RE, Greenberg PL.

Leuk Res. 1998 Sep;22(9):767-77.PMID: 9716007 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors and scoring systems in myelodysplastic syndromes.

Sanz GF, Sanz MA, Greenberg PL.

Haematologica. 1998 Apr;83(4):358-68. Review.PMID: 9592987 [PubMed - indexed for MEDLINE]Related articlesFree article

Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.

Rajapaksa R, Ginzton N, Rott LS, Greenberg PL.

Blood. 1996 Dec 1;88(11):4275-87.PMID: 8943864 [PubMed - indexed for MEDLINE]Related articlesFree article

Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.

Negrin RS, Stein R, Doherty K, Cornwell J, Vardiman J, Krantz S, Greenberg PL.

Blood. 1996 May 15;87(10):4076-81.PMID: 8639764 [PubMed - indexed for MEDLINE]Related articlesFree article

Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes.

Greenberg PL.

Semin Hematol. 1996 Apr;33(2):163-75. Review. No abstract available. PMID: 8722686 [PubMed - indexed for MEDLINE]Related articles

Modulation of apoptosis in human myeloid leukemic cells by GM-CSF.

Han JH, Gileadi C, Rajapaksa R, Kosek J, Greenberg PL.

Exp Hematol. 1995 Mar;23(3):265-72.PMID: 7875243 [PubMed - indexed for MEDLINE]Related articles

Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes.

Nagler A, MacKichan ML, Negrin RS, Donlon T, Greenberg PL.

Leukemia. 1995 Jan;9(1):30-9.PMID: 7531261 [PubMed - indexed for MEDLINE]Related articles

Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.

Greenberg PL.

Semin Hematol. 1993 Oct;30(4 Suppl 6):22-4. Review. No abstract available. PMID: 8153674 [PubMed - indexed for MEDLINE]Related articles

Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin.

Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S, Greenberg PL.

Blood. 1993 Aug 1;82(3):737-43.PMID: 7687889 [PubMed - indexed for MEDLINE]Related articlesFree article

The use of colony stimulating factors in clinical bone marrow transplantation.

Negrin RS, Greenberg PL.

Curr Opin Immunol. 1992 Oct;4(5):567-70. Review.PMID: 1418720 [PubMed - indexed for MEDLINE]Related articles

In vitro marrow culture studies in the myelodysplastic syndromes.

Greenberg PL.

Semin Oncol. 1992 Feb;19(1):34-46. Review. No abstract available. PMID: 1736368 [PubMed - indexed for MEDLINE]Related articles

Treatment of myelodysplastic syndromes with hemopoietic growth factors.

Greenberg PL.

Semin Oncol. 1992 Feb;19(1):106-14. Review. No abstract available. PMID: 1371018 [PubMed - indexed for MEDLINE]Related articles

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.

Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, Fleming NC, Bonnem EM, Greenberg PL.

Ann Intern Med. 1992 Feb 1;116(3):183-9.PMID: 1345803 [PubMed - indexed for MEDLINE]Related articles

Therapy of hematopoietic disorders with recombinant colony-stimulating factors.

Negrin RS, Greenberg PL.

Adv Pharmacol. 1992;23:263-96. Review. No abstract available. PMID: 1540537 [PubMed - indexed for MEDLINE]Related articles

Treatment of myelodysplastic syndromes.

Greenberg PL.

Blood Rev. 1991 Mar;5(1):42-50. Review.PMID: 1709576 [PubMed - indexed for MEDLINE]Related articles

Effects of insulin-like growth factors on hemopoiesis.

Greenberg PL.

Blood Cells. 1991;17(2):344-6; discussion 347-8. No abstract available. PMID: 1912599 [PubMed - indexed for MEDLINE]Related articles

Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells.

Oksenberg D, Dieckmann BS, Greenberg PL.

Cancer Res. 1990 Oct 15;50(20):6471-7.PMID: 1698537 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of CSFs in preleukemia.

Greenberg PL, Negrin R, Nagler A.

Bone Marrow Transplant. 1990 Jul;6 Suppl 1:121-6. Review.PMID: 1697191 [PubMed - indexed for MEDLINE]Related articles

Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor.

Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL.

Blood. 1990 Jul 1;76(1):36-43.PMID: 1694702 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone marrow cell modulation and inhibition of myelopoiesis by large granular lymphocytes and natural killer cells.

Nagler A, Greenberg PL.

Int J Cell Cloning. 1990 May;8(3):171-83.PMID: 2140585 [PubMed - indexed for MEDLINE]Related articlesFree article

The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes.

Greenberg PL, Negrin R, Nagler A.

Cancer Surv. 1990;9(1):199-212. Review.PMID: 2276114 [PubMed - indexed for MEDLINE]Related articles

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.

Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, Souza LM, Greenberg PL.

Ann Intern Med. 1989 Jun 15;110(12):976-84.PMID: 2471429 [PubMed - indexed for MEDLINE]Related articles